AR028333A1 - Antegenos de leishmania para la terapia y el diagnnstico de leishmaniasis - Google Patents

Antegenos de leishmania para la terapia y el diagnnstico de leishmaniasis

Info

Publication number
AR028333A1
AR028333A1 ARP010101749A ARP010101749A AR028333A1 AR 028333 A1 AR028333 A1 AR 028333A1 AR P010101749 A ARP010101749 A AR P010101749A AR P010101749 A ARP010101749 A AR P010101749A AR 028333 A1 AR028333 A1 AR 028333A1
Authority
AR
Argentina
Prior art keywords
diagnnsis
leishmaniasis
leishmania
antigens
therapy
Prior art date
Application number
ARP010101749A
Other languages
English (en)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/551,974 external-priority patent/US6500437B1/en
Priority claimed from US09/565,501 external-priority patent/US6607731B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AR028333A1 publication Critical patent/AR028333A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ARP010101749A 2000-04-14 2001-04-11 Antegenos de leishmania para la terapia y el diagnnstico de leishmaniasis AR028333A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/551,974 US6500437B1 (en) 1995-09-22 2000-04-14 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US09/565,501 US6607731B1 (en) 1995-09-22 2000-05-05 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US09/639,206 US6613337B1 (en) 1997-02-12 2000-08-14 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Publications (1)

Publication Number Publication Date
AR028333A1 true AR028333A1 (es) 2003-05-07

Family

ID=27415636

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101749A AR028333A1 (es) 2000-04-14 2001-04-11 Antegenos de leishmania para la terapia y el diagnnstico de leishmaniasis

Country Status (10)

Country Link
US (1) US6613337B1 (es)
EP (2) EP1287026B1 (es)
AR (1) AR028333A1 (es)
AT (1) ATE310746T1 (es)
AU (1) AU2001255241A1 (es)
DE (1) DE60115230T2 (es)
ES (2) ES2255553T3 (es)
MX (1) MXPA02010173A (es)
PT (1) PT1681301E (es)
WO (1) WO2001079276A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000069456A2 (en) * 1999-05-13 2000-11-23 American Cyanamid Company Adjuvant combination formulations
EP1255562B1 (en) * 2000-02-18 2008-01-16 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens
HUP0600589A2 (en) * 2000-11-10 2006-11-28 Wyeth Corp Adjuvant combination formulations
US7833534B2 (en) 2006-04-10 2010-11-16 Infectious Disease Research Institute Compounds and methods for diagnosis and treatment of leishmaniasis
BRPI0815565A2 (pt) 2007-07-13 2015-02-18 Infectious Disease Res Inst Composições de esterol 24-c-metiltransferase de leishmania para a prevenção, tratamento e diagnóstico de leishmaniose.
US8410258B2 (en) 2008-05-21 2013-04-02 Infections Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
AR073170A1 (es) 2008-05-21 2010-10-20 Infectious Disease Res Inst Vacunas de poliproteinas recombinantes para el tratamiento y diagnostico de leishmaniasis
AR073452A1 (es) 2008-07-03 2010-11-10 Infectious Disease Res Inst Proteinas de fusion que comprende dos o mas antigenos de leishmania y su uso en el diagnostico y tratamiento de leishmaniasis
BRPI0900961B8 (pt) * 2009-03-23 2021-07-13 Fundacao Oswaldo Cruz métodos e kit para diagnóstico de leishmaniose
WO2011006891A1 (en) 2009-07-13 2011-01-20 Laboratorios Leti, S.L. Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe)
WO2014091463A1 (pt) * 2012-12-14 2014-06-19 Universidade Federal De Minas Gerais - Ufmg Processo para produção de proteínas recombinantes de leishmania e uso em kit para diagnóstico e vacina contra leishmanioses
ES2728865T3 (es) 2013-03-28 2019-10-29 Infectious Disease Res Inst Vacunas que comprenden polipéptidos de Leishmania para el tratamiento y el diagnóstico de la leishmaniasis
US20140356391A1 (en) * 2013-05-29 2014-12-04 Jose Antonio O'Daly Amino acid sequences for clinical remission of psoriasis and related diseases.
JP2016053535A (ja) * 2014-09-04 2016-04-14 国立大学法人 東京大学 皮膚型リーシュマニア症の検査用試薬又はキット、及び皮膚型リーシュマニア症の検査方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
US5411865A (en) 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US5879687A (en) 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
WO1995029239A2 (en) 1994-04-22 1995-11-02 Corixa Corporation Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
US5876735A (en) 1994-04-22 1999-03-02 Corixa Corporation Methods for enhancement of protective immune responses
US6013268A (en) 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US5912166A (en) 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US5965142A (en) 1995-08-04 1999-10-12 Corixa Corporation Polypeptides and methods for the detection of L. tropica infection
US5834592A (en) 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US5744593A (en) * 1996-02-15 1998-04-28 Heska Corporation Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules
US5910306A (en) 1996-11-14 1999-06-08 The United States Of America As Represented By The Secretary Of The Army Transdermal delivery system for antigen
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US5846748A (en) 1996-11-15 1998-12-08 The Council Of Scientific & Industrial Research Method for diagnosing visceral leishmaniasis in a patient by identification of a new key marker namely 9-O-acetylated sialoglycoconjugate
BR9807332A (pt) 1997-02-12 2000-10-31 Corixa Corp Antìgenos de leishmania para utilização na terapia e diagnóstico de leishmaniose
IL143956A0 (en) * 1998-12-23 2002-04-21 Leti Lab Chimeric gene encoding the antigenic determinants of four proteins of l.infantum

Also Published As

Publication number Publication date
EP1287026B1 (en) 2005-11-23
ES2255553T3 (es) 2006-07-01
EP1681301A1 (en) 2006-07-19
WO2001079276A2 (en) 2001-10-25
ATE310746T1 (de) 2005-12-15
ES2391562T3 (es) 2012-11-27
MXPA02010173A (es) 2003-06-04
DE60115230T2 (de) 2006-08-03
EP1287026A2 (en) 2003-03-05
PT1681301E (pt) 2012-10-26
US6613337B1 (en) 2003-09-02
EP1681301B1 (en) 2012-07-18
WO2001079276A3 (en) 2002-09-06
DE60115230D1 (de) 2005-12-29
AU2001255241A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
DK1414471T3 (da) Terapeutiske midler omfattende pro-apoptotiske proteiner
DE60221504D1 (de) Wabenstrukturkörper
AR028333A1 (es) Antegenos de leishmania para la terapia y el diagnnstico de leishmaniasis
PT981334E (pt) Comprimido para engolir compreendendo paracetamol
PT1206436E (pt) Retinoides para o tratamento de enfisema
PT9493U (pt) Cabeca para esfregona
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
DE60230292D1 (de) Aktivsauerstoff erzeugendes material
PT1381620E (pt) Dissacaridos hipersulfatados e metodos de utilizacao dos mesmos para o tratamento de inflamacoes
AR028398A1 (es) Ciclipostinas, procedimiento para su preparacion, y utilizacion de las mismas
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
AU2002305811A1 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
AR028334A1 (es) Lona para toldos y procedimiento para su fabricacion
AR028328A1 (es) Proceso para la preparacion de heterociclos benzo-fusionados
FR2821754B1 (fr) Descenceur autobloquant
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
PT1073627E (pt) Processos para a preparacao de intermediarios pesticidas
AR016434A1 (es) Procedimiento para preparar clorobenzoxazoles
AR028111A1 (es) Procedimiento para la produccion de isocianatos
IT1316654B1 (it) Procedimento per la realizzazione di un fascicolo e simili coninserito un dischetto e simili
ITMI20001865A0 (it) Procedimento e miscela per la preparazione di solfuri metallici
ES1050413Y (es) Prensador para elaboracion de salazones y analogos.
PT9448T (pt) Puncao vulcanizado aperfeicoado para o fabrico de azulejos
ES1047360Y (es) Mastil para soporte y fijacion de luminarias y similares.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee